Literature DB >> 17668695

Maximal inspiratory pressure predicts mortality in patients with chronic obstructive pulmonary disease in a five-year follow-up.

Vladimir A Hodgev1, Stefan S Kostianev.   

Abstract

INTRODUCTION: The therapeutic modality for the treatment of COPD depends on the proper determination of all factors that may have an effect on the course and prognosis of the disease. AIM: To assess the prognostic role of maximal inspiratory pressure (PImax) and a large group of lung function parameters in patients with COPD followed up over a period of five years. PATIENTS AND METHODS: A cohort of 63 COPD patients (age 58.6 +/- 8.8 yrs, BMI 24.2 +/- 5.6, FEV1% = 35 +/- 14%, PImax = 52.3 +/- 19.0 cm H2O; x +/- S x) was recruited for a 5-year prospective study. Mortality was assessed as overall mortality. The independent predictors of survival were determined using the Cox proportional hazards model.
RESULTS: The deceased patients (n = 32) had lower values of BMI, FEV1, DL(CO)/V(A)%, PaO2, PImax, and six-minute walking test (6MWT) and higher RV/TLC% (p < 0.05) than the survivors. The regression model included the following parameters: age, BMI, smoking history, FEV1, FVC, DL(CO)/V(A)%, lung hyperinflation (RV/TLC%), PImax, PaO2, PaCO2, hematocrit, mean pulmonary artery pressure (mPAP - Doppler echocardiography), symptoms (Anthonisen scale), dyspnea, comorbidity (Charlson index), frequency of exacerbations in the previous year, and the exercise capacity (6MWT). Statistical analysis indicated that PImax was an independent predictor of mortality (p = 0.005).
CONCLUSION: Low PImax was associated with greater overall mortality rate in this cohort of patients with COPD.

Entities:  

Mesh:

Year:  2006        PMID: 17668695

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  6 in total

1.  The Efficacy of Expiratory Muscle Training during Inspiratory Load in Healthy Adult Males: A Randomized Controlled Trial.

Authors:  Toshiya Tsukamoto; Michitaka Kato; Yasunari Kurita; Masaki Uchida; Akira Kubo; Hitoshi Maruyama
Journal:  Healthcare (Basel)       Date:  2022-05-18

2.  Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease.

Authors:  F de Blasio; M G Santaniello; F de Blasio; G Mazzarella; A Bianco; L Lionetti; F M E Franssen; L Scalfi
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

3.  Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings.

Authors:  David Hui; Swati Bansal; Margarita Morgado; Rony Dev; Gary Chisholm; Eduardo Bruera
Journal:  Cancer       Date:  2014-06-04       Impact factor: 6.860

Review 4.  Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Authors:  Benedikt Schoser; Edward Fong; Tarekegn Geberhiwot; Derralynn Hughes; John T Kissel; Shyam C Madathil; David Orlikowski; Michael I Polkey; Mark Roberts; Harm A W M Tiddens; Peter Young
Journal:  Orphanet J Rare Dis       Date:  2017-03-16       Impact factor: 4.123

5.  The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications.

Authors:  Magno F Formiga; Isabel Vital; Gisel Urdaneta; Kira Balestrini; Lawrence P Cahalin; Michael A Campos
Journal:  SAGE Open Med       Date:  2018-12-12

6.  Muscle metabolomics analysis reveals potential biomarkers of exercise‑dependent improvement of the diaphragm function in chronic obstructive pulmonary disease.

Authors:  Jian Li; Yufan Lu; Ning Li; Peijun Li; Jianqing Su; Zhengrong Wang; Ting Wang; Zhaoyu Yang; Yahui Yang; Haixia Chen; Lu Xiao; Hongxia Duan; Weibing Wu; Xiaodan Liu
Journal:  Int J Mol Med       Date:  2020-03-12       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.